CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-17 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,292 | $30.86 | $102K | 58,631 |
| 2023-04-17 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −58,631 | $30.86 | $1.8M | 0 |
| 2023-03-31 | SOUTHWELL DAVID P Director | Option exercise 10b5-1 | +2,571 | $18.01 | $46K | 13,071 |
| 2023-03-31 | SOUTHWELL DAVID P Director | Sale 10b5-1 | −2,571 | $50.05 | $129K | 10,500 |
| 2023-03-31 | SOUTHWELL DAVID P Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,571 | $18.01 | $46K | 11,429 |
| 2023-03-29 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise 10b5-1 | +4,688 | $40.45 | $190K | 42,747 |
| 2023-03-29 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −3,247 | $47.80 | $155K | 39,500 |
| 2023-03-29 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −1,441 | $47.78 | $69K | 38,059 |
| 2023-03-29 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,688 | $40.45 | $190K | 0 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise 10b5-1 | +16,929 | $33.02 | $559K | 54,988 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −7,949 | $44.72 | $355K | 47,039 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −8,780 | $45.42 | $399K | 38,259 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −200 | $46.01 | $9K | 38,059 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise 10b5-1 | +9,729 | $33.02 | $321K | 47,788 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −4,475 | $44.71 | $200K | 43,313 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −4,954 | $45.38 | $225K | 38,359 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −300 | $46.01 | $14K | 38,059 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,929 | $33.02 | $559K | 4,321 |
| 2023-03-27 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,729 | $33.02 | $321K | 371 |
| 2023-03-27 | SOUTHWELL DAVID P Director | Option exercise 10b5-1 | +10,000 | $27.05 | $271K | 20,500 |
Page 40 of 41 · 804 trades